{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:09:03Z","timestamp":1782932943671,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372766"],"award-info":[{"award-number":["81372766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572532"],"award-info":[{"award-number":["81572532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372766"],"award-info":[{"award-number":["81372766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372766"],"award-info":[{"award-number":["81372766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572532"],"award-info":[{"award-number":["81572532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Liaoning \u201cClimbing\u201d scholarship"},{"name":"the Liaoning \u201cClimbing\u201d scholarship."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41417-018-0064-8","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T13:13:51Z","timestamp":1542633231000},"page":"323-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway"],"prefix":"10.1038","volume":"26","author":[{"given":"Gejun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhuo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuize","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"64_CR1","volume-title":"GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide [Internet]","author":"JSI Ferlay","year":"2013","unstructured":"Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide [Internet]. Lyon: International Agency for Research on Cancer; 2013. http:\/\/globocan.iarc.fr."},{"key":"64_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.toxlet.2005.02.013","volume":"157","author":"Y Xu","year":"2005","unstructured":"Xu Y, Chen X, Li Y. Ercc6l, a gene of SNF2 family, may play a role in the teratogenic action of alcohol. Toxicol Lett. 2005;157:233\u20139.","journal-title":"Toxicol Lett"},{"key":"64_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2006.11.041","volume":"128","author":"C Baumann","year":"2007","unstructured":"Baumann C, Korner R, Hofmann K, Nigg EA. PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint. Cell. 2007;128:101\u201314.","journal-title":"Cell"},{"key":"64_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/35065617","volume":"410","author":"F Toyoshima-Morimoto","year":"2001","unstructured":"Toyoshima-Morimoto F, Taniguchi E, Shinya N, Iwamatsu A, Nishida E. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature. 2001;410:215\u201320.","journal-title":"Nature"},{"key":"64_CR5","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1083\/jcb.135.6.1701","volume":"135","author":"HA Lane","year":"1996","unstructured":"Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol. 1996;135:1701\u201313.","journal-title":"J Cell Biol"},{"key":"64_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1083\/jcb.201106093","volume":"195","author":"K Lee","year":"2011","unstructured":"Lee K, Rhee K. PLK1 phosphorylation of pericentrin initiates centrosome maturation at the onset of mitosis. J Cell Biol. 2011;195:1093\u2013101.","journal-title":"J Cell Biol"},{"key":"64_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.onc.1208279","volume":"24","author":"DM Glover","year":"2005","unstructured":"Glover DM. Polo kinase and progression through M phase in Drosophila: a perspective from the spindle poles. Oncogene. 2005;24:230\u20137.","journal-title":"Oncogene"},{"key":"64_CR8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1073\/pnas.91.5.1736","volume":"91","author":"U Holtrich","year":"1994","unstructured":"Holtrich U, Wolf G, Brauninger A, Karn T, Bohme B, Rubsamen-Waigmann H, et al. Induction and down-regulation of PLK, a human serine\/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci USA. 1994;91:1736\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"64_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.onc.1200862","volume":"14","author":"G Wolf","year":"1997","unstructured":"Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene. 1997;14:543\u20139.","journal-title":"Oncogene"},{"key":"64_CR10","first-page":"2794","volume":"59","author":"R Knecht","year":"1999","unstructured":"Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res. 1999;59:2794\u20137.","journal-title":"Cancer Res"},{"key":"64_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.onc.1208272","volume":"24","author":"N Takai","year":"2005","unstructured":"Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. Polo-like kinases (Plks) and cancer. Oncogene. 2005;24:287\u201391.","journal-title":"Oncogene"},{"key":"64_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.molcel.2013.07.016","volume":"51","author":"A Biebricher","year":"2013","unstructured":"Biebricher A, Hirano S, Enzlin JH, Wiechens N, Streicher WW, Huttner D, et al. PICH: a DNA translocase specially adapted for processing anaphase bridge DNA. Mol Cell. 2013;51:691\u2013701.","journal-title":"Mol Cell"},{"key":"64_CR13","first-page":"1480","volume":"7","author":"M Leng","year":"2008","unstructured":"Leng M, Besusso D, Jung SY, Wang Y, Qin J. Targeting Plk1 to chromosome arms and regulating chromosome compaction by the PICH ATPase. Cold Sh Q B. 2008;7:1480\u20139.","journal-title":"Cold Sh Q B"},{"key":"64_CR14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1091\/mbc.e09-11-0950","volume":"21","author":"Y Kurasawa","year":"2010","unstructured":"Kurasawa Y, Yu-Lee LY. PICH and cotargeted Plk1 coordinately maintain prometaphase chromosome arm architecture. Mol Biol Cell. 2010;21:1188\u201399.","journal-title":"Mol Biol Cell"},{"key":"64_CR15","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1038\/onc.2013.340","volume":"33","author":"J Nie","year":"2014","unstructured":"Nie J, Liu L, Xing G, Zhang M, Wei R, Guo M, et al. CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation. Oncogene. 2014;33:3677\u201387.","journal-title":"Oncogene"},{"key":"64_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell . 2011;144:646\u201374.","journal-title":"Cell"},{"key":"64_CR17","first-page":"3446","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Ann NY Acad Sci. 2014;120:3446\u201356.","journal-title":"Ann NY Acad Sci"},{"key":"64_CR18","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1074\/jbc.270.13.7161","volume":"270","author":"JL Duff","year":"1995","unstructured":"Duff JL, Monia BP, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J Biol Chem. 1995;270:7161\u20136.","journal-title":"J Biol Chem"},{"key":"64_CR19","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1074\/jbc.271.11.6497","volume":"271","author":"Y Chu","year":"1996","unstructured":"Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem. 1996;271:6497\u2013501.","journal-title":"J Biol Chem"},{"key":"64_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1096\/fasebj.14.1.6","volume":"14","author":"M Camps","year":"2000","unstructured":"Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 2000;14:6\u201316.","journal-title":"FASEB J"},{"key":"64_CR21","doi-asserted-by":"publisher","first-page":"16491","DOI":"10.1074\/jbc.M010966200","volume":"276","author":"DN Slack","year":"2001","unstructured":"Slack DN, Seternes OM, Gabrielsen M, Keyse SM. Distinct binding determinants for ERK2\/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem. 2001;276:16491\u2013500.","journal-title":"J Biol Chem"},{"key":"64_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.molcel.2008.01.019","volume":"29","author":"A O\u2019Donnell","year":"2008","unstructured":"O\u2019Donnell A, Yang S-H, Sharrocks AD. MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch. Mol Cell. 2008;29:780\u20135.","journal-title":"Mol Cell"},{"key":"64_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ncb822","volume":"4","author":"LO Murphy","year":"2002","unstructured":"Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol. 2002;4:556\u201364.","journal-title":"Nat Cell Biol"},{"key":"64_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cellsig.2006.09.001","volume":"19","author":"CJ Chalmers","year":"2007","unstructured":"Chalmers CJ, Gilley R, March HN, Balmanno K, Cook SJ. The duration of ERK 1\/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal. 2007;19:695\u2013704.","journal-title":"Cell Signal"},{"key":"64_CR25","doi-asserted-by":"publisher","first-page":"42116","DOI":"10.18632\/oncotarget.14998","volume":"8","author":"SY Pu","year":"2017","unstructured":"Pu SY, Yu Q, Wu H, Jiang JJ, Chen XQ, He YH, et al. ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers. Oncotarget. 2017;8:42116\u201324.","journal-title":"Oncotarget"},{"key":"64_CR26","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1021\/cr000241p","volume":"101","author":"Z Chen","year":"2001","unstructured":"Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, et al. MAP kinases. Chem Rev. 2001;101:2449\u201376.","journal-title":"Chem Rev"},{"key":"64_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37\u201340.","journal-title":"Nature"},{"key":"64_CR28","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","volume":"23","author":"T Wada","year":"2004","unstructured":"Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838\u201349.","journal-title":"Oncogene"},{"key":"64_CR29","first-page":"153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153\u201383.","journal-title":"Endocr Rev"},{"key":"64_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0955-0674(96)80067-6","volume":"8","author":"R Treisman","year":"1996","unstructured":"Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996;8:205\u201315.","journal-title":"Curr Opin Cell Biol"},{"key":"64_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","volume":"21","author":"NE Hynes","year":"2009","unstructured":"Hynes NE, MacDonald G. ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol. 2009;21:177\u201384.","journal-title":"Curr Opin Cell Biol"},{"key":"64_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3:459\u201365.","journal-title":"Nat Rev Cancer"},{"key":"64_CR33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546\u201358.","journal-title":"Science"},{"key":"64_CR34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PT Wan","year":"2004","unstructured":"Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855\u201367.","journal-title":"Cell"},{"key":"64_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11\u201322.","journal-title":"Nat Rev Cancer"},{"key":"64_CR36","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1038\/sj.onc.1210412","volume":"26","author":"DM Owens","year":"2007","unstructured":"Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene. 2007;26:3203\u201313.","journal-title":"Oncogene"},{"key":"64_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0955-0674(99)00075-7","volume":"12","author":"SM Keyse","year":"2000","unstructured":"Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000;12:186\u201392.","journal-title":"Curr Opin Cell Biol"},{"key":"64_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, et al. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov. 2006;5:835\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"64_CR39","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1158\/1078-0432.CCR-13-2054","volume":"20","author":"AM Menzies","year":"2014","unstructured":"Menzies AM, Long GV. Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma. Clin Cancer Res. 2014;20:2035\u201343.","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1038\/s41417-021-00417-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000}}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0064-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T07:03:45Z","timestamp":1660806225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-018-0064-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":39,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["64"],"URL":"https:\/\/doi.org\/10.1038\/s41417-018-0064-8","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"1 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41417-021-00417-2","URL":"https:\/\/doi.org\/10.1038\/s41417-021-00417-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}